Susan Fennewald

Title: Susan Fennewald: Innovator in Viral Infection Treatment

Introduction

Susan Fennewald is a prominent inventor based in The Woodlands, TX (US). She has made significant contributions to the field of viral infection treatment, holding a total of 5 patents. Her innovative work focuses on the development of guanosine-rich oligonucleotides that have the potential to treat various viral infections.

Latest Patents

Fennewald's latest patents include groundbreaking methods and compositions for treating viral infections both in vitro and in vivo. One of her notable inventions is a method utilizing guanosine-rich oligonucleotide integrase inhibitors. These oligonucleotides are designed to form a guanosine tetrad, which is crucial for their anti-viral activity. Additionally, she has developed methods for designing guanosine-rich oligonucleotides that exhibit integrase inhibition activity, specifically targeting HIV.

Career Highlights

Throughout her career, Susan Fennewald has worked with reputable organizations, including Aronex Pharmaceuticals, Inc. and the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work has been instrumental in advancing the understanding and treatment of viral infections.

Collaborations

Fennewald has collaborated with notable professionals in her field, including Robert F. Rando and Joseph G. Zendegui. These collaborations have further enhanced her research and development efforts in the area of viral infection treatment.

Conclusion

Susan Fennewald's innovative contributions to the field of viral infection treatment through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for new therapeutic approaches in combating viral diseases.